[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Aptargroup (ATR)

Aptargroup (ATR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,250,589
  • Shares Outstanding, K 63,820
  • Annual Sales, $ 3,777 M
  • Annual Income, $ 392,790 K
  • EBIT $ 793 M
  • EBITDA $ 1,080 M
  • 60-Month Beta 0.42
  • Price/Sales 1.96
  • Price/Cash Flow 11.34
  • Price/Book 2.79

Options Overview Details

View History
  • Implied Volatility 29.44% (-0.42%)
  • Historical Volatility 24.31%
  • IV Percentile 68%
  • IV Rank 59.48%
  • IV High 36.31% on 03/30/26
  • IV Low 19.35% on 08/12/25
  • Expected Move (DTE 29) 6.21 (5.43%)
  • Put/Call Vol Ratio 999.99
  • Today's Volume 1
  • Volume Avg (30-Day) 16
  • Put/Call OI Ratio 0.38
  • Today's Open Interest 256
  • Open Int (30-Day) 444
  • Expected Range 108.11 to 120.52

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $1.35
  • Number of Estimates 4
  • High Estimate $1.39
  • Low Estimate $1.33
  • Prior Year $1.66
  • Growth Rate Est. (year over year) -18.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
111.55 +2.60%
on 05/20/26
132.25 -13.46%
on 04/21/26
-16.47 (-12.58%)
since 04/20/26
3-Month
111.55 +2.60%
on 05/20/26
146.91 -22.10%
on 02/24/26
-30.61 (-21.10%)
since 02/20/26
52-Week
103.23 +10.87%
on 10/31/25
164.28 -30.34%
on 07/24/25
-44.08 (-27.81%)
since 05/20/25

Most Recent Stories

More News
AptarGroup Sets CEO Succession as 2025 Sales Rise and Shareholders Back Ballot

AptarGroup (NYSE:ATR) used its annual meeting to announce a planned chief executive transition, report that shareholders approved all items on the ballot and provide an update on 2025 performance and early...

ATR : 114.85 (+1.09%)
AptarGroup: Q1 Earnings Snapshot

AptarGroup: Q1 Earnings Snapshot

ATR : 114.85 (+1.09%)
Aptar Reports First Quarter 2026 Results

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dispensing, dosing and protection technologies, today reported the following first quarter results for the period ended...

ATR : 114.85 (+1.09%)
Aptar Declares Quarterly Dividend

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, including dosing and protection technologies, and consumer product dispensing, today announced that the Board declared a quarterly cash dividend...

ATR : 114.85 (+1.09%)
Aptar Digital Health Partners with Enable Injections for enFuse® Companion Digital Solution

Digital solution will be designed to help guide users through injection process

ATR : 114.85 (+1.09%)
Aptar’s Unidose Powder Nasal Delivery System Used in ENA Respiratory Phase II Clinical Study of Investigational INNA‑051 Nasal Spray

Use of Aptar Pharma’s UDS Powder system supports the development of a next‑generation, virus‑agnostic nasal spray being evaluated for its potential to help protect against symptomatic viral respiratory...

ATR : 114.85 (+1.09%)
Aptar Announces Gael Touya as its Next Chief Executive Officer; Stephan B. Tanda to Retire by the End of the Year

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that Gael Touya, a seasoned global executive with more...

ATR : 114.85 (+1.09%)
Aptar to Participate in Upcoming Investor Conferences

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery and consumer product dispensing, dosing and protection technologies, today announced that it will present at two upcoming investor conferences:...

ATR : 114.85 (+1.09%)
AptarGroup: Q4 Earnings Snapshot

AptarGroup: Q4 Earnings Snapshot

ATR : 114.85 (+1.09%)
Aptar Reports Fourth Quarter and Annual 2025 Results

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dispensing, dosing and protection technologies, today reported the following fourth quarter results for the period ended...

ATR : 114.85 (+1.09%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

AptarGroup, Inc. is a leading global supplier of a broad range of innovative dispensing systems for the beauty, personal care, home care, prescription drug, consumer health care, injectables, food and beverage markets. AptarGroup is headquartered in Crystal Lake, Illinois, with manufacturing facilities...

See More

Key Turning Points

3rd Resistance Point 119.21
2nd Resistance Point 117.63
1st Resistance Point 115.62
Last Price 114.85
1st Support Level 112.02
2nd Support Level 110.44
3rd Support Level 108.43

See More

52-Week High 164.28
Fibonacci 61.8% 140.96
Fibonacci 50% 133.75
Fibonacci 38.2% 126.55
Last Price 114.85
52-Week Low 103.23

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.